281 related articles for article (PubMed ID: 38424367)
1. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers).
Yadav KS; Upadhya A; Misra A
Expert Opin Drug Deliv; 2021 Jan; 18(1):103-118. PubMed ID: 33017541
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
5. Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices.
Yu XY; Jin X; Shou ZX
Drug Deliv; 2021 Dec; 28(1):1995-2010. PubMed ID: 34569401
[TBL] [Abstract][Full Text] [Related]
6. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
7. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
8. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnological Systems and Lung: A Perfect Combination for Lung Pharmaceutical Applications.
Santonocito D; Puglia C
Curr Med Chem; 2023; 30(6):725-743. PubMed ID: 36043745
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
12. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
13. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-based inhalation treatments for lung cancer: state of the art.
Ahmad J; Akhter S; Rizwanullah M; Amin S; Rahman M; Ahmad MZ; Rizvi MA; Kamal MA; Ahmad FJ
Nanotechnol Sci Appl; 2015; 8():55-66. PubMed ID: 26640374
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary delivery of anti-inflammatory agents.
Ali ME; McConville JT; Lamprecht A
Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
20. Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC).
Ashique S; Garg A; Mishra N; Raina N; Ming LC; Tulli HS; Behl T; Rani R; Gupta M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2769-2792. PubMed ID: 37219615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
